Skip to Content

Join the 'Pancreatic Cancer' group to help and get support from people like you.

Pancreatic Cancer News

Related terms: Cancer, Pancreas, Cancer, Pancreatic, Pancreatic Carcinoma

Blood Test for Pancreatic Cancer Shows Early Promise

Posted 24 May 2017 by Drugs.com

WEDNESDAY, May 24, 2017 – Scientists say they've developed a new blood test for identifying pancreatic cancer – a step that might eventually allow earlier diagnosis. Pancreatic cancer is a particularly deadly type of tumor because it's often detected too late for effective treatment. The still-experimental test detects a bundle of proteins churned out by pancreatic tumors. And it appears to be more accurate than a currently available test for a protein called CA19-9, according to the study findings. That CA 19-9 test is "very imperfect," said Dr. Cesar Castro, one of the researchers on the new study. For one, levels of CA 19-9 often rise only in the later stages of pancreatic cancer, according to Castro, an oncologist at Massachusetts General Hospital in Boston. Plus, a spike in the protein is not specific to the cancer. It can go up when the pancreas is inflamed, for example, or when ... Read more

Related support groups: Cancer, Breast Cancer, Colonoscopy, Colorectal Cancer, Pancreatic Cancer

Not All Hospitals Equal When It Comes to Pancreatic Cancer Care

Posted 8 May 2017 by Drugs.com

MONDAY, May 8, 2017 – When it comes to treating pancreatic cancer, where you have your surgery may have some impact on how long you live, according to a new study. The researchers found that people who travel to an academic medical center to undergo surgery for pancreatic cancer live a few months longer than those who choose to have their operation at a hospital closer to home. High-volume surgical centers also tended to provide better care for patients with pancreatic or thyroid cancer, but few people opt to travel for their surgery, the study authors said. "Little was known about whether traveling to receive surgical cancer care results in differences in perioperative outcomes and overall survival," said senior investigator Dr. Raymon Grogan. He is an assistant professor of surgery at the University of Chicago Medicine. "Yet, there is a well-established relationship between a ... Read more

Related support groups: Thyroid Cancer, Pancreatic Cancer, Diagnosis and Investigation

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Osteosarcoma, Endometrial Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Another Study Ties Obesity to Certain Cancers

Posted 1 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – Carrying extra weight increases the risk of a number of cancers, a new review reports. Additional pounds appear to particularly influence the risk of cancers related to the digestive organs or those driven by hormonal abnormalities, according to the review's European authors. The evidence is so strong at this point that important organizations such as the International Agency for Research on Cancer describe "excess body weight as an important cause of cancers," said Susan Gapstur. She's vice president of epidemiology at the American Cancer Society. The new evidence review was led by Maria Kyrgiou, of Imperial College London's Department of Surgery and Cancer. The review found that a jump in a person's body mass index (BMI) of 5 was associated with a higher cancer risk in the esophagus, bone marrow, biliary tract system, pancreas and kidneys. BMI is a rough ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Stomach Cancer, Gastric Cancer, Wilms' Tumor, Solid Tumors, Neoplasm of Bone, Peritoneal Cancer, Insulinoma, Giant Cell Tumor of Bone

Is There a Link Between Diabetes and Pancreatic Cancer?

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – Developing or worsening type 2 diabetes could be an early sign of pancreatic cancer, new research suggests. Researchers analyzed data from nearly a million patients with type 2 diabetes or pancreatic cancer in Italy and Belgium. Half of all pancreatic cancer cases were diagnosed within a year of patients being diagnosed with diabetes, the findings showed. The investigators also found that type 2 diabetes patients whose condition deteriorated rapidly requiring more aggressive treatment were also at increased risk for pancreatic cancer. The study findings, which don't prove an association between type 2 diabetes and pancreatic cancer, were presented Monday at the European Cancer Congress (ECC) in Amsterdam. Research presented at medical meetings is typically considered preliminary until published in a peer-reviewed journal. "Doctors and their diabetic patients ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Glucophage, Glipizide, Novolog, Humalog, Janumet, Glyburide, Lantus Solostar, Levemir, Glimepiride, Pancreatic Cancer, Novolin R, Amaryl, Novolin N, Humulin N, Glucophage XR, Lantus Solostar Pen

Mental Health May Affect Chances Against Cancer

Posted 26 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Anxiety and depression may increase the risk of death from certain cancers, early research suggests. After analyzing studies involving thousands of patients in Great Britain, researchers found that people with greater levels of psychological distress had higher death rates for colon, esophageal, pancreatic and prostate cancers and leukemia. The study was published Jan. 25 in the BMJ. "Our findings contribute to the evidence that poor mental health might have some predictive capacity for certain physical diseases, but we are a long way off from knowing if these relationships are truly causal," said researcher David Batty in a journal news release. Batty is with University College London. He and his colleagues reviewed 16 English and Scottish studies that included more than 163,000 people, aged 16 and older. The people were initially cancer-free and followed ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Major Depressive Disorder, Prostate Cancer, Colorectal Cancer, Psychiatric Disorders, Dysthymia, Pancreatic Cancer, Head and Neck Cancer

Daily Low-Dose Aspirin May Cut Pancreatic Cancer Risk

Posted 20 Dec 2016 by Drugs.com

TUESDAY, Dec. 20, 2016 – There's evidence that daily low-dose aspirin may decrease the risk of pancreatic cancer, according to a new study. The Chinese-based study couldn't prove cause-and-effect. However, "the balance of evidence shows that people who use aspirin to reduce risk for cardiovascular disease or colorectal cancer can feel positive that their use likely also lowers their risk for pancreatic cancer," said study lead author Dr. Harvey Risch. He's professor of epidemiology at the Yale School of Public Health and Yale Cancer Center in New Haven, Conn. According to the American Cancer Society, about 53,000 Americans will be diagnosed with pancreatic cancer this year, and almost 42,000 will die from the disease. Pancreatic cancer is often a "silent killer" because symptoms do not emerge until the tumor is advanced. The new study tracked 761 people diagnosed with pancreatic cancer ... Read more

Related support groups: Aspirin, Excedrin, Colorectal Cancer, Aggrenox, Alka-Seltzer, Pancreatic Cancer, Fiorinal, Excedrin Migraine, Arthritis Pain, Prevention of Cardiovascular Disease, Ecotrin, Cardiovascular Risk Reduction, Fiorinal with Codeine, Soma Compound, Norgesic, Arthritis Pain Formula, Bayer Aspirin, Excedrin Extra Strength, Norgesic Forte, Percodan

Women's Cancer Risk Rises With Years Spent Overweight

Posted 16 Aug 2016 by Drugs.com

TUESDAY, Aug. 16, 2016 – The longer a woman is overweight, the higher her risk of several cancers, researchers report. The study, which followed nearly 74,000 U.S. women, found that the longer a woman carried excess poundage, the greater her risk of breast, endometrial, colon and kidney cancers. "We've known for a long time that excess weight is important in cancer risk," said Susan Gapstur, vice president of epidemiology for the American Cancer Society. The cancer society says excess weight contributes to as many as 20 percent of all cancer deaths. "This study is interesting because it suggests that the number of years you spend being overweight also matters," said Gapstur, who was not involved in the research. And that, she said, should provide further incentive to avoid excess weight gain in the first place. Currently, about 7 out of 10 adults in the United States are overweight, ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Bladder Cancer, Urinary Tract Cancer

Health Insurance Status May Affect Cancer Patients' Survival

Posted 8 Aug 2016 by Drugs.com

MONDAY, Aug. 8, 2016 – Two large studies suggest that surviving certain cancers in America could depend on your health insurance status. Despite improvements in cancer diagnosis and treatment, patients who were uninsured or had Medicaid coverage were more likely to suffer worse outcomes, compared with people who have other forms of health insurance, the studies found. People who were uninsured or relied on Medicaid were diagnosed at a later stage, received sub-optimal treatment and had shorter survival, the findings showed. In the case of testicular cancer, they were at greater risk of death from their disease than patients with other insurance, the researchers found. The findings, published online Aug. 8 in the journal Cancer, add to evidence linking poor outcomes and inadequate health insurance. Dr. Christopher Sweeney, a medical oncologist at the Dana-Farber Cancer Institute in ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Basal Cell Carcinoma, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Melanoma - Metastatic, Cervical Cancer

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Hydrocodone, Tramadol, Percocet, Methadone, Cancer, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Chronic Pain, Tylenol, Opana, Ibuprofen, Naproxen

Global Recession May Have Contributed to Cancer Deaths

Posted 26 May 2016 by Drugs.com

THURSDAY, May 26, 2016 – The 2008 global economic crisis has been linked to a sharp rise in deaths from cancer, a new study reports. Unemployment and cuts in public health-care spending were associated with more than 260,000 additional cancer deaths by 2010. Most of those deaths – 160,000 – were in the European Union, the researchers said. The study included 70 countries and a total of more than 2 billion people, according to the report published online May 25 in The Lancet. "Cancer is a leading cause of death worldwide, so understanding how economic changes affect cancer survival is crucial," lead author Dr. Mahiben Maruthappu, of Imperial College London, said in a journal news release. "We found that increased unemployment was associated with increased cancer mortality, but that universal health coverage protected against these effects. This was especially the case for treatable ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Bladder Cancer, Melanoma - Metastatic, Cervical Cancer, Stomach Cancer, Breast Cancer - Palliative, Testicular Cancer, Gastric Cancer, Solid Tumors

Too Many Advanced Cancer Patients Lack Info About Their Disease

Posted 23 May 2016 by Drugs.com

MONDAY, May 23, 2016 – Many patients battling advanced cancer lack basic information about their prognosis or treatment, meaning they can't make informed decisions about their care, a small new study suggests. "These were people with highly lethal metastatic cancers that had progressed after at least one prior line of chemotherapy; their life expectancy was approximately four months from our interview," said lead researcher Dr. Holly Prigerson. She is a professor of geriatrics at Weill Cornell Medicine in New York City. "We were astonished to learn that only 5 percent of this sample had sufficient knowledge about their illness to make informed decisions about their care," Prigerson said in a Weill Cornell news release. The findings highlight the need for doctors to improve communication with these patients, she said. In the study, Prigerson's team compared 178 advanced cancer patients' ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic, Stomach Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Testicular Cancer, Gastric Cancer, Solid Tumors

Additional Treatments Offer Little Benefit for Pancreatic Cancer: Study

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – Additional treatments for locally advanced pancreatic cancer don't appear to boost survival, a new French study reports. Researchers looked at the effects of adding a second drug – erlotinib (Tarceva) – to the initial round of chemotherapy. They also tested whether adding radiation to a second round of chemotherapy (chemoradiotherapy) would offer any survival benefit. Unfortunately, the addition of the second drug didn't help people live longer, and those on chemoradiotherapy didn't fare any better. "Chemoradiotherapy was not superior to chemotherapy," said the study's senior author, Dr. Pascal Hammel. Hammel is from the department of gastroenterology-pancreatology at Beaujon Hospital, in Clichy, France. The study was funded by the pharmaceutical company Roche, the maker of Tarceva, and the French National Institute of Cancer. More than 53,000 Americans are ... Read more

Related support groups: Tarceva, Pancreatic Cancer, Nausea/Vomiting - Chemotherapy Induced, Erlotinib, History - Radiation Therapy

Could Talk Therapy Ease Chemo-Related Memory Issues?

Posted 2 May 2016 by Drugs.com

MONDAY, May 2, 2016 – A type of psychotherapy might help cancer survivors deal with the long-term thinking problems some experience after chemotherapy, researchers say. It's estimated that about half of those who undergo chemotherapy for cancer develop what's often called "chemo brain." For instance, they may have trouble following conversations or remembering the steps in a project, according to background notes with the new study. Although usually mild, these changes can affect quality of life, job performance and relationships, said the researchers from the Eastern Maine Medical Center and Lafayette Family Cancer Center in Bangor, Maine. The researchers developed a cognitive-behavioral therapy (CBT) program called Memory and Attention Adaptation Training to help cancer survivors prevent or manage these memory problems. Their study involved 47 breast cancer survivors who underwent ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Lung Cancer, Gleevec, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Xeloda, Skin Cancer, Tasigna, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Hydroxyurea

Study Ties Certain Mouth Germs to Pancreatic Cancer Risk

Posted 20 Apr 2016 by Drugs.com

WEDNESDAY, April 20, 2016 – A new study suggests a possible link between certain germs found in the mouth and a heightened risk of pancreatic cancer. "We identified two types of bacteria that are associated with a higher risk for pancreatic cancer and have been tied in the past to such diseases as periodontitis, or inflammation of the gums," explained lead researcher Jiyoung Ahn. She's an associate professor of population health at NYU Langone Medical Center, in New York City. Ahn stressed, however, that her team found only an association and "cannot tell if this bacteria causes the cancer." One strain of mouth bacteria was associated with a 59 percent higher risk for pancreatic cancer in people who carried it, while the other was linked to a 119 percent greater risk of the cancer, the researchers said. Those numbers reflect a person's risk of developing pancreatic cancer compared to ... Read more

Related support groups: Oral and Dental Conditions, Gingivitis, Pancreatic Cancer, Periodontitis, Stomatitis, Diagnosis and Investigation, Prevention of Dental Caries

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, fluorouracil, Tarceva, Sutent, Afinitor, capecitabine, gemcitabine, Gemzar, sunitinib, view more... mitomycin, everolimus, pancreatin, erlotinib, Abraxane, bevacizumab, cetuximab, Adrucil, Pan-2400, Pancreatin 4X, Hi-Vegi-Lip, Digipepsin, Onivyde, irinotecan liposomal, paclitaxel protein-bound, streptozocin, Mutamycin, Zanosar, Donnazyme